Grundium is excited to announce a strategic partnership with Fisher Healthcare, a part of Thermo Fisher Scientific, to enhance the U.S. market presence of its Ocus scanners.
TAMPERE, Finland – April 2, 2024 – Grundium, a pioneering force in digital pathology, is excited to announce a strategic partnership with Fisher Healthcare, a part of Thermo Fisher Scientific, to enhance the U.S. market presence of its Ocus scanners. The partnership leverages Fisher Healthcare’s established distribution presence and expertise in the healthcare sector, making it an ideal partner for Grundium, with innovative diagnostic solutions like Ocus.
Ocus scanners offer an unparalleled combination of quality, ease of use, and affordability, providing a unique solution to streamline diagnostic processes in pathology.
Joshua Griffith, Vice President and General Manager of Grundium US, who will be leading the implementation of this partnership, is enthusiastic about the new relationship:
“This is an exciting opportunity for us. This partnership makes the Ocus scanners more accessible for hospitals and laboratories throughout the United States, aligning perfectly with our mission to enhance pathology services’ efficiency and accessibility. We are eager to see this collaboration bring us closer to transforming the future of pathology diagnostics.“
With this strategic partnership, Grundium renews its unwavering dedication to revolutionizing digital pathology. By ensuring that its compact, high-performance Ocus scanners reach a wider audience, Grundium supports healthcare professionals in delivering more efficient workflows and faster diagnostic outcomes, ultimately contributing to superior patient care.
For further information about Grundium and the Ocus scanners and to explore how these advanced tools can enhance your diagnostic processes, don’t hesitate to get in touch with Joshua Griffith at joshua.griffith@grundium.com.
